0000000000179042

AUTHOR

Xavier Roblin

0000-0002-7929-4878

showing 1 related works from this author

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

2013

International audience; OBJECTIVE: To explore the risk of new or recurrent cancer among patients with IBD and previous cancer, exposed or not to immunosuppressants. DESIGN: Among the 17 047 patients of the CESAME prospective observational cohort who were enrolled from May 2004 to June 2005, and followed-up until December 2007, we identified 405 patients with cancer diagnosed previous to study entry. We calculated the rates of incident cancer in patients with or without previous cancer, and we assessed by survival analysis and nested case-control study the impact of immunosuppressants on the risk of incident new or recurrent cancer in patients with previous cancer. RESULTS: The rate of incid…

OncologyAdultMalemedicine.medical_specialtyAzathioprineKaplan-Meier EstimateCrohn Disease[ CHIM.ORGA ] Chemical Sciences/Organic chemistryRisk FactorsInternal medicineNeoplasmsEpidemiology of cancermedicineHumansProspective StudiesSurvival analysisAgedProportional Hazards ModelsCrohn's diseasebusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryIncidence (epidemiology)IncidenceGastroenterologyCancerMiddle Agedmedicine.diseaseUlcerative colitis3. Good healthSurgeryCase-Control StudiesCohortMultivariate AnalysisColitis UlcerativeFemaleNeoplasm Recurrence LocalbusinessImmunosuppressive Agentsmedicine.drugFollow-Up Studies
researchProduct